Conditions: Neuroblastoma; Ewing's Sarcoma; Wilm's Tumor; Retinoblastoma; Glioma
Intervention: Drug: racotumomab
Sponsors: Laboratorio Elea S.A.C.I.F. y A.; Laboratorio Elea S.A.C.I.F. y A.; Ministry of Science and Technology; Netherlands: Ministry of Health, Welfare and Sports
Recruiting - verified May 2012
Feeds
4580 items (4580 unread) in 80 feeds
Acinar Cell Carcinoma
(28 unread)
Acinic Cell Carcinoma
(32 unread)
Adenoid Cystic Carcinoma
(56 unread)
Adrenal Gland Cancer
(327 unread)
Ampulla Of Vater
(14 unread)
Anal Cancer
(252 unread)
Angiosarcoma
(72 unread)
Appendix Cancer
(34 unread)
Bile Duct Cancer
(385 unread)
Brain and CNS
(1133 unread)
Carcinoid
(143 unread)
Endocrine/Neuroendocrine
(291 unread)
Gall Bladder Cancer
(223 unread)
Hemangioendothelioma
(23 unread)
Hepatoblastoma
(30 unread)
Pancreas
(45 unread)
Phyllodes
(21 unread)
PMP and Mucinous Tumors
(19 unread)
Rhabdomyosarcoma
(186 unread)
Sarcoma
(600 unread)
Twitter Pals
(666 unread)
Trial - Sarcoma (67 unread)
-
Use of Racotumomab in Patients With Pediatric Tumors Expressing N-glycolylated Gangliosides
Posted: May 10th, 2012, 8:00am MDT
-
Treatment With Medroxyprogesterone Acetate Plus LNG-IUS in Young Women With Early Stage Endometrial Cancer
Posted: May 7th, 2012, 8:00am MDT
Condition: Endometrial Cancer
Intervention: Device: MIrena(LNG-IUS), oral MPA
Sponsors: Korean Gynecologic Oncology Group; Korean Gynecologic Oncology Group
Recruiting - verified May 2012 -
A Treatment Trial Comparing Gemcitabine and Pazopanib Versus Gemcitabine and Docetaxel for Patients With Advanced Soft Tissue Sarcoma
Posted: May 4th, 2012, 8:00am MDT
Condition: Sarcoma
Interventions: Drug: Gemcitabine and Pazopanib; Drug: Gemcitabine and Docetaxel
Sponsors: Medical University of South Carolina; Medical University of South Carolina; GlaxoSmithKline
Not yet recruiting - verified May 2012 -
Aerosol IL-2 for Pulmonary Metastases
Posted: April 30th, 2012, 8:00am MDT
Conditions: Sarcoma; Solid Tumors; Pulmonary Metastases; Lung Metastases; Osteosarcomas; Ewing Sarcoma
Interventions: Drug: Aerosol IL-2; Procedure: Symptom Assessment
Sponsors: M.D. Anderson Cancer Center; M.D. Anderson Cancer Center; Shannon Wilkes Foundation
Not yet recruiting - verified May 2012 -
Contribution of F18-FDG PET/CT to the Early Assessment of Pazopanib Therapy Efficacy in Advanced Soft Tissue Sarcoma
Posted: April 30th, 2012, 8:00am MDT
Condition: Soft Tissue Sarcoma (STS)
Intervention: Other: F18-FGD PET/CT
Sponsors: Hadassah Medical Organization; Hadassah Medical Organization
Not yet recruiting - verified April 2012 -
A Open-Label, Multiple Ascending Dose Study of DS-3078a, an Oral TORC1/2 Kinase Inhibitor, in Subjects With Advanced Solid Tumors or Lymphomas
Posted: April 26th, 2012, 8:00am MDT
Conditions: Advanced Solid Tumor; Lymphoma
Intervention: Drug: DS-3078a
Sponsors: Daiichi Sankyo Inc.; Daiichi Sankyo Inc.
Recruiting - verified April 2012 -
Studying Genes in Samples From Younger Patients With Rhabdomyosarcoma
Posted: April 24th, 2012, 8:00am MDT
Condition: Sarcoma
Interventions: Genetic: mutation analysis; Genetic: nucleic acid sequencing; Other: laboratory biomarker analysis
Sponsors: National Cancer Institute (NCI); Children's Oncology Group; National Cancer Institute (NCI)
Active, not recruiting - verified April 2012 -
Intensity-Modulated Radiation Therapy in Treating Younger Patients With Lung Metastases
Posted: April 23rd, 2012, 8:00am MDT
Conditions: Adult Rhabdomyosarcoma; Lung Metastases; Metastatic Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor; Previously Treated Childhood Rhabdomyosarcoma; Recurrent Adult Soft Tissue Sarcoma; Recurrent Childhood Rhabdomyosarcoma; Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor; Recurrent Wilms Tumor and Other Childhood Kidney Tumors; Stage IV Adult Soft Tissue Sarcoma; Stage IV Wilms Tumor; Stage V Wilms Tumor; Unspecified Adult Solid Tumor, Protocol Specific; Unspecified Childhood Solid Tumor, Protocol Specific
Intervention: Radiation: intensity-modulated radiation therapy
Sponsors: Children's Memorial Hospital; Children's Memorial Hospital; Northwestern University; National Cancer Institute (NCI)
Recruiting - verified April 2012 -
A Survivorship Care Plan for Gynaecological Cancer Patients
Posted: April 20th, 2012, 8:00am MDT
Conditions: Adenocarcinoma of the Gastroesophageal Junction; Cervical Cancer; Endometrial Cancer; Esophageal Cancer; Fallopian Tube Cancer; Gastric Cancer; Ovarian Cancer; Sarcoma; Vaginal Cancer; Vulvar Cancer
Intervention:
Sponsors: Royal Marsden NHS Foundation Trust; Royal Marsden NHS Foundation Trust; University of Surrey
Recruiting - verified April 2012 -
Olaparib in Adults With Recurrent/Metastatic Ewing's Sarcoma
Posted: April 18th, 2012, 8:00am MDT
Condition: Ewing's Sarcoma
Intervention: Drug: Olaparib
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital
Not yet recruiting - verified April 2012 -
PK/PD of XM22 in Children With Ewing Family of Tumors or Rhabdomyosarcoma
Posted: April 18th, 2012, 8:00am MDT
Condition: Ewing Family of Tumors, Rhabdomyosarcoma
Intervention: Drug: Lipegfilgrastim
Sponsors: Teva Pharmaceutical Industries; Merckle GmbH
Not yet recruiting - verified May 2012 -
Phase Ib Trial of Folate Binding Protein Vaccine in Ovarian Cancer
Posted: April 16th, 2012, 8:00am MDT
Conditions: Ovarian Cancer; Endometrial Cancer
Interventions: Biological: E39 peptide vaccine; Other: Clinical tracking for disease progression/recurrence
Sponsors: San Antonio Military Medical Center; COL George Peoples, MD, FACS
Recruiting - verified April 2012 -
Study of Safety and Efficacy of Gemcitabine and Docetaxel With MORAb-004 in Metastatic Soft Tissue Sarcoma
Posted: April 4th, 2012, 8:00am MDT
Condition: Metastatic Soft Tissue Sarcoma
Interventions: Drug: MORAb-004; Drug: Gemcitabine; Drug: Docetaxel
Sponsors: Morphotek; Morphotek
Not yet recruiting - verified April 2012 -
Clinical Relevance of ROS (V-ros UR2 Sarcoma Virus Oncogene Homolog) Aberrations in Solid Tumours
Posted: April 2nd, 2012, 8:00am MDT
Condition: Cancer
Intervention:
Sponsors: National University Hospital, Singapore; National University Hospital, Singapore
Recruiting - verified April 2012 -
Collaborative Advanced Stage Tissue Lung Cancer (CASTLE) Network
Posted: March 28th, 2012, 8:00am MDT
Conditions: Non-small Cell Lung Cancer Metastatic; Small Cell Lung Carcinoma
Intervention: Other: therapeutic interventions
Sponsors: Vanderbilt-Ingram Cancer Center; David P. Carbone, M.D. PhD; Addario Lung Cancer Institute (ALCMI)
Recruiting - verified April 2012 -
Studying Genes in Tissue Samples From Younger and Adolescent Patients With Soft Tissue Sarcomas
Posted: March 27th, 2012, 8:00am MDT
Conditions: Chordoma; Desmoid Tumor; Sarcoma
Interventions: Genetic: DNA analysis; Genetic: microarray analysis; Genetic: polymerase chain reaction; Other: laboratory biomarker analysis; Other: mass spectrometry
Sponsors: National Cancer Institute (NCI); Children's Oncology Group; National Cancer Institute (NCI)
Active, not recruiting - verified March 2012 -
Acupuncture Point Stimulation for Treatment of Chemotherapy Nausea and Vomiting
Posted: December 13th, 2011, 8:00am MST
Conditions: Childhood Acute Lymphoblastic Leukemia; Childhood Acute Myeloid Leukemia/Other Myeloid Malignancies; Ewing Sarcoma; Vomiting in Infants and/or Children; Osteosarcoma
Interventions: Procedure: electroacupuncture therapy; Other: questionnaire administration; Procedure: electroacupuncture therapy
Sponsors: Stanford University; Stanford University; National Cancer Institute (NCI)
Recruiting - verified May 2012 -
Pilot Study Using a PET Gamma Probe to Evaluate Lymph Nodes in Endometrial Cancer
Posted: October 19th, 2011, 8:00am MDT
Condition: Endometrial Cancer
Interventions: Procedure: lymphadenectomy; Procedure: therapeutic conventional therapy; Procedure: Positron Emission Tomography/ Computed Tomography; Radiation: fludeoxyglucose F 18
Sponsors: University Health Network, Toronto; University Health Network, Toronto
Recruiting - verified May 2012 -
Vincristine and Irinotecan With or Without Temozolomide in Children and Adults With Refractory or Relapsed Rhabdomyosarcoma : International Randomized Trial
Posted: May 16th, 2011, 8:00am MDT
Condition: RHABDOMYOSARCOMA
Interventions: Drug: Vincristine, Irinotecan; Drug: Vincristine-Irinotecan-Temozolomide
Sponsors: Centre Oscar Lambret; Centre Oscar Lambret; SFCE
Recruiting - verified May 2012 -
Study to Assess Safety and Tolerability of Oral CC-115 for Patients With Advanced Solid Tumors, Non-Hodgkin's Lymphoma or Multiple Myeloma
Posted: May 12th, 2011, 8:00am MDT
Conditions: Multiple Myeloma; Non-Hodgkin's Lymphoma; Glioblastoma Multiforme; Head and Neck Squamous Cell Cancer; Triple Negative Breast Cancer; Hormone Receptor-Positive Breast Cancer; Castration-Resistant Prostate Cancer; Ewing's Family of Sarcomas
Intervention: Drug: CC-115
Sponsors: Celgene Corporation; Celgene Corporation
Recruiting - verified May 2012 -
High Dose Intensity Modulated Proton Radiation Treatment +/- Surgical Resection of Sarcomas of the Spine, Sacrum and Base of Skull
Posted: April 28th, 2011, 8:00am MDT
Conditions: Chordoma of Spine; Chordoma of Sacrum; Chordoma of Base of Skull; Chondrosarcoma of the Spine; Chondrosarcoma of the Sacrum
Intervention: Radiation: High Dose Intensity Modulated Proton Radiation
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital; M.D. Anderson Cancer Center; National Cancer Institute (NCI)
Not yet recruiting - verified May 2012 -
Maximum Tolerated Dose Study of Belinostat (PXD-101)in Combination With Paclitaxel Plus Carboplatin in Chemotherapy-Naive Patients With Stage IV Non-Small-Cell Lung Cancer (NSCLC)
Posted: February 28th, 2011, 8:00am MST
Condition: Stage IV Non-small Cell Lung Cancer
Intervention: Drug: Belionstat, Carboplatin, Paclitaxel
Sponsors: Spectrum Pharmaceuticals, Inc; Spectrum Pharmaceuticals, Inc; TopoTarget A/S
Recruiting - verified May 2012 -
Continuing vs Intermittent Trabectedin-regimen in Patients With Advanced Soft Tissue Sarcoma Experiencing Response or Stable Disease After the 6th Cycle
Posted: February 23rd, 2011, 8:00am MST
Conditions: Soft Tissue Sarcoma; Uterine Sarcoma
Interventions: Drug: Trabectedin; Other: Drug: holiday
Sponsors: Centre Oscar Lambret; Centre Oscar Lambret; Groupe Sarcome Français; Groupe d’études des Tumeurs Osseuses
Recruiting - verified May 2012 -
Effects of Maraviroc (MVC) on HIV-related Kaposi's Sarcoma (KS)
Posted: December 20th, 2010, 8:00am MST
Condition: Kaposi's Sarcoma
Intervention: Drug: Maraviroc
Sponsors: University of California, San Francisco; University of California, San Francisco; Pfizer; ViiV Healthcare
Enrolling by invitation - verified May 2012 -
To Evaluate the Safety, Activity and Pharmacokinetics of Marqibo in Children and Adolescents With Refractory Cancer
Posted: October 15th, 2010, 8:00am MDT
Conditions: Sarcoma; Neuroblastoma; Wilms Tumor; Leukemia; Lymphoma; Brain Tumors
Intervention: Drug: Marqibo
Sponsors: Talon Therapeutics, Inc; Talon Therapeutics, Inc; National Cancer Institute (NCI)
Recruiting - verified May 2012 -
Metformin and Endometrial Cancer
Posted: September 17th, 2010, 8:00am MDT
Condition: Endometrial Cancer
Intervention: Drug: Metformin
Sponsors: M.D. Anderson Cancer Center; M.D. Anderson Cancer Center; American Cancer Society
Recruiting - verified May 2012 -
Surveillance Study of Patients With Newly Diagnosed Osteosarcoma
Posted: September 1st, 2010, 8:00am MDT
Condition: Osteosarcoma
Intervention: Drug: Mifamurtide
Sponsors: Millennium Pharmaceuticals, Inc.; Millennium Pharmaceuticals, Inc.
Recruiting - verified April 2012 -
Study of Palifosfamide-tris in Combination With Doxorubicin in Patients With Front-line Metastatic Soft Tissue Sarcoma
Posted: July 21st, 2010, 8:00am MDT
Condition: Soft Tissue Sarcoma
Interventions: Drug: doxorubicin in combination with palifosfamide-tris; Drug: doxorubicin in combination with placebo
Sponsors: ZIOPHARM; ZIOPHARM
Recruiting - verified April 2012 -
A Study of RO5045337 in Patients With Liposarcomas Prior to Debulking Surgery
Posted: June 11th, 2010, 8:00am MDT
Condition: Sarcoma
Intervention: Drug: RO5045337
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Completed - verified May 2012 -
Study of Oral Darinaparsin in Patients With Advanced Solid Tumors
Posted: June 4th, 2010, 8:00am MDT
Condition: Advanced Solid Tumors
Intervention: Drug: darinaparsin
Sponsors: ZIOPHARM; ZIOPHARM
Completed - verified May 2012 -
Seneca Valley Virus-001 and Cyclophosphamide in Treating Young Patients With Relapsed or Refractory Neuroblastoma, Rhabdomyosarcoma, or Rare Tumors With Neuroendocrine Features
Posted: January 13th, 2010, 8:00am MST
Conditions: Adrenocortical Carcinoma; Gastrointestinal Carcinoid Tumor; Kidney Cancer; Neuroblastoma; Retinoblastoma; Sarcoma
Interventions: Biological: Seneca Valley virus-001; Drug: cyclophosphamide; Other: laboratory biomarker analysis; Other: pharmacological study
Sponsors: National Cancer Institute (NCI); Children's Oncology Group; National Cancer Institute (NCI)
Recruiting - verified May 2012 -
Genomic Analysis of Pediatric Bone Tumors
Posted: January 11th, 2010, 8:00am MST
Condition: Bone Cancer
Intervention:
Sponsors: Stanford University; Stanford University
Recruiting - verified May 2012 -
Quantitative MR Biomarkers for Sarcoma Treatment
Posted: November 20th, 2009, 8:00am MST
Condition: Soft Tissue Tumors
Intervention: Procedure: MRI Scan of soft tissue tumor
Sponsors: University of Michigan; University of Michigan; National Institutes of Health (NIH)
Completed - verified April 2012 -
Safety Study of PLX108-01 in Patients With Solid Tumors
Posted: October 28th, 2009, 8:00am MDT
Conditions: Solid Tumors; Mucoepidermal Carcinoma (MEC) of the Salivary Gland; Pigmented Villo-nodular Synovitis (PVNS); Gastrointestinal Stromal Tumors (GIST); Anaplastic Thyroid Carcinoma (ATC); Solid Tumors With Documented Malignant Pleural or Peritoneal Effusions; Malignant Peripheral Nerve Sheath Tumor (MPNST); Neurofibromatosis Type I (NF-1); Melanoma; Schwannomatosis
Intervention: Drug: PLX3397
Sponsors: Plexxikon; Plexxikon
Recruiting - verified May 2012 -
Pazopanib Hydrochloride in Treating Young Patients With Solid Tumors That Have Relapsed or Not Responded to Treatment
Posted: June 27th, 2009, 8:00am MDT
Conditions: Brain and Central Nervous System Tumors; Sarcoma; Unspecified Childhood Solid Tumor, Protocol Specific
Interventions: Drug: pazopanib hydrochloride; Other: pharmacological study
Sponsors: National Cancer Institute (NCI); Children's Oncology Group; National Cancer Institute (NCI)
Active, not recruiting - verified August 2011 -
A Study of Ridaforolimus in Non-Small Cell Lung Cancer (NSCLC) Patients With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutations (MK-8669-021 AM1)
Posted: January 7th, 2009, 8:00am MST
Condition: Non-Small Cell Lung Cancer
Interventions: Drug: Lead-In Ridaforolimus; Drug: Comparator: Blinded Ridaforolimus; Drug: Comparator: Blinded Placebo
Sponsors: Merck; Merck; Ariad Pharmaceuticals
Active, not recruiting - verified May 2012 -
A Placebo-Controlled Study Evaluating the Potential Effects of Trabectedin on the Heart in Patients With Advanced Cancer
Posted: November 4th, 2008, 8:00am MST
Condition: Neoplasm Metastases
Intervention: Drug: trabectedin
Sponsors: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.; Johnson & Johnson Pharmaceutical Research & Development, L.L.C.; PharmaMar
Completed - verified May 2012 -
Combined Biological Treatment and Chemotherapy for Patients With Inoperable Cholangiocarcinoma
Posted: October 22nd, 2008, 8:00am MDT
Condition: Cholangiocarcinoma
Interventions: Drug: Gemcitabine, Oxaliplatin, Capecitabine,; Drug: Panitumumab, Gemcitabine, Oxaliplatin, Capecitabine
Sponsors: Vejle Hospital; Vejle Hospital
Recruiting - verified May 2012 -
Treatment of Patients With RAD001 Who Have Progressive Sarcoma
Posted: October 6th, 2008, 8:00am MDT
Condition: Progressive Sarcoma
Intervention: Drug: Everolimus/RAD001
Sponsors: Novartis; Novartis Pharmaceuticals
Recruiting - verified April 2012 -
Evaluation of Paclitaxel (Taxol, NSC #673089), Carboplatin (Paraplatin, NSC #241240), and BSI-201 (NSC #746045, IND #71,677) in the Treatment of Advanced, Persistent, or Recurrent Uterine Carcinosarcoma
Posted: May 28th, 2008, 8:00am MDT
Condition: Uterine Carcinosarcoma
Intervention: Drug: Carboplatin, paclitaxel, BSI-201
Sponsors: Sanofi-Aventis; Sanofi-Aventis; BiPar Sciences; Gynecologic Oncology Group
Completed - verified May 2012 -
Combination Chemotherapy in Treating Patients With Sarcoma
Posted: April 18th, 2008, 8:00am MDT
Conditions: Ovarian Cancer; Sarcoma
Interventions: Drug: cyclophosphamide; Drug: doxorubicin hydrochloride; Drug: etoposide; Drug: ifosfamide; Drug: vincristine sulfate; Procedure: adjuvant therapy; Procedure: neoadjuvant therapy; Procedure: therapeutic conventional surgery; Radiation: brachytherapy; Radiation: intraoperative radiation therapy; Radiation: radiation therapy
Sponsors: Mayo Clinic; Mayo Clinic; National Cancer Institute (NCI)
Active, not recruiting - verified May 2012 -
Dynamic Contrast Enhanced MRI(DCE-MRI)of Bone Tumors
Posted: January 10th, 2008, 8:00am MST
Conditions: Sarcoma; Bone Tumor
Intervention: Other: DCE-MRI
Sponsors: Memorial Sloan-Kettering Cancer Center; Memorial Sloan-Kettering Cancer Center; New York Presbyterian Hospital; University of Oregon; University College, London; Montefiore Hospital
Active, not recruiting - verified May 2012 -
Collection of Tissue & Blood From Patients w/ Benign & Malignant Tumors of the Soft Tissue & Gastrointestinal Tract
Posted: December 21st, 2007, 8:00am MST
Conditions: Esophageal Cancer; Bile Duct Neoplasms; Gastric Cancer; Liver Cancer; Melanoma; Pancreatic Cancer; Sarcoma
Intervention:
Sponsors: Memorial Sloan-Kettering Cancer Center; Memorial Sloan-Kettering Cancer Center; National Cancer Institute (NCI)
Recruiting - verified May 2012 -
Evaluation of Carboplatin/Paclitaxel/Bevacizumab in the Treatment of Advanced Stage Endometrial Carcinoma
Posted: August 8th, 2007, 8:00am MDT
Condition: Endometrial Cancer
Intervention: Drug: Carboplatin/Paclitaxel/Bevacizumab
Sponsors: Ohio State University; David O'Malley; Genentech
Active, not recruiting - verified May 2012 -
Safety and Efficacy Study of REOLYSIN® in the Treatment of Bone and Soft Tissue Sarcomas Metastatic to the Lung
Posted: July 16th, 2007, 8:00am MDT
Conditions: Osteosarcoma; Ewing Sarcoma Family Tumors; Malignant Fibrous Histiocytoma; Sarcoma, Synovial; Fibrosarcoma; Leiomyosarcoma
Intervention: Biological: REOLYSIN®
Sponsors: Oncolytics Biotech; Oncolytics Biotech
Completed - verified May 2012 -
Study of Insulin Resistance and Endometrial Cancer in Harris County, Texas
Posted: July 2nd, 2007, 8:00am MDT
Condition: Endometrial Cancer
Intervention: Behavioral: Questionnaire
Sponsors: M.D. Anderson Cancer Center; M.D. Anderson Cancer Center
Recruiting - verified April 2012 -
Development of Serologic Assays for Human Herpes Virus-8
Posted: October 31st, 2006, 8:00am MST
Condition: Herpesvirus 8, Human
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institutes of Health Clinical Center (CC)
Completed - verified June 2011 -
Racial Disparity in Endometrial Cancer
Posted: September 11th, 2006, 8:00am MDT
Condition: Endometrial Cancer
Intervention:
Sponsors: James Graham Brown Cancer Center; James Graham Brown Cancer Center
Terminated - verified April 2012 -
Evaluate PKs and Efficacy Assessment of Palifermin in Patients With Sarcoma
Posted: December 19th, 2005, 8:00am MST
Conditions: Sarcoma; Oral Mucositis
Interventions: Drug: Palifermin; Drug: Placebo; Drug: Adriamycin (Doxorubicin); Drug: Ifosfamide; Drug: Vincristine; Drug: Cisplatin
Sponsors: M.D. Anderson Cancer Center; M.D. Anderson Cancer Center
Completed - verified April 2012 -
A Phase II Trial of Adjuvant Radiation Therapy With Ifosfamide in Patients With MMT of the Uterus
Posted: October 3rd, 2005, 8:00am MDT
Condition: Uterine Cancer
Interventions: Drug: Ifosfamide; Procedure: Radiation Therapy
Sponsors: Montefiore Medical Center; Montefiore Medical Center
Completed - verified April 2012 -
Imatinib Mesylate in Patients With Various Types of Malignancies Involving Activated Tyrosine Kinase Enzymes
Posted: September 13th, 2005, 8:00am MDT
Conditions: Hypereosinophilic Syndrome; Systemic Mastocytosis; Chronic Myelomonocytic Leukemia; Dermatofibrosarcoma
Intervention: Drug: imatinib mesylate
Sponsors: Novartis; Novartis Pharmaceuticals
Recruiting - verified April 2012 -
Traumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell Transplantation
Posted: April 7th, 2004, 8:00am MDT
Conditions: Kidney Cancer; Leukemia; Lymphoma; Neuroblastoma; Oral Complications; Sarcoma
Intervention: Dietary Supplement: Traumeel S
Sponsors: National Cancer Institute (NCI); Children's Oncology Group; National Cancer Institute (NCI)
Completed - verified November 2010 -
Soblidotin in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma
Posted: July 8th, 2003, 8:00am MDT
Condition: Sarcoma
Intervention: Drug: soblidotin
Sponsors: Daiichi Sankyo Inc.; Daiichi Sankyo Inc.; National Cancer Institute (NCI)
Completed - verified May 2012 -
Exatecan Mesylate in Treating Patients With Ewing's Sarcoma, Primitive Neuroectodermal Tumor, or Desmoplastic Small Round Cell Tumor
Posted: March 6th, 2003, 8:00am MST
Condition: Sarcoma
Intervention: Drug: exatecan mesylate
Sponsors: Daiichi Sankyo Inc.; Daiichi Sankyo Inc.
Completed - verified May 2012 -
Exatecan Mesylate in Treating Children With Relapsed or Refractory Rhabdomyosarcoma
Posted: March 6th, 2003, 8:00am MST
Condition: Sarcoma
Intervention: Drug: exatecan mesylate
Sponsors: Daiichi Sankyo Inc.; Daiichi Sankyo Inc.
Completed - verified May 2012 -
Vincristine, Doxorubicin, Cyclophosphamide and Dexrazoxane (VACdxr) in High Risk Ewing's Sarcoma Patients
Posted: May 29th, 2002, 8:00am MDT
Condition: Ewing's Sarcoma
Interventions: Drug: Vincristine; Drug: Doxorubicin; Drug: Cyclophosphamide; Drug: Dexrazoxane; Biological: ImmTher
Sponsors: M.D. Anderson Cancer Center; M.D. Anderson Cancer Center
Active, not recruiting - verified May 2012 -
UCN-01 and Irinotecan in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple-Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)
Posted: March 8th, 2002, 8:00am MST
Condition: Cancer
Interventions: Drug: 7-hydroxystaurosporine; Drug: irinotecan hydrochloride; Other: laboratory biomarker analysis
Sponsors: National Cancer Institute (NCI); University of Virginia; National Cancer Institute (NCI); Washington University Siteman Cancer Center
Completed - verified August 2009 -
Phase I Trial of the Combination of Zidovudine and Recombinant Interleukin-2 in Patients With Persistent Generalized Lymphadenopathy
Posted: November 2nd, 1999, 8:00am MST
Condition: HIV Infections
Interventions: Drug: Zidovudine; Drug: Aldesleukin
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID)
Completed - verified April 2012 -
A Phase I Study of the Combination of Recombinant GM-CSF, AZT, and Chemotherapy (ABV) (Adriamycin, Bleomycin, Vincristine) in AIDS and Kaposi's Sarcoma
Posted: November 2nd, 1999, 8:00am MST
Conditions: Sarcoma, Kaposi; HIV Infections
Interventions: Drug: Bleomycin sulfate; Drug: Vincristine sulfate; Drug: Doxorubicin hydrochloride; Drug: Zidovudine; Drug: Sargramostim
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID)
Completed - verified April 2012 -
A Phase I/II Study of Recombinant Interleukin-4 in AIDS and Kaposi's Sarcoma
Posted: November 2nd, 1999, 8:00am MST
Conditions: Sarcoma, Kaposi; HIV Infections
Intervention: Drug: Interleukin-4
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID)
Completed - verified April 2012 -
Open Label Phase I Study To Evaluate the Safety of Combination Therapy With AZT and Interferon-Beta in Patients With AIDS Related Kaposi's Sarcoma
Posted: November 2nd, 1999, 8:00am MST
Conditions: Sarcoma, Kaposi; HIV Infections
Interventions: Drug: Interferon beta-1b; Drug: Zidovudine
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID)
Completed - verified May 2012 -
A Phase I Trial of Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor (rHuGM-CSF), Recombinant Alpha Interferon and Azidothymidine (AZT) in AIDS-Associated Kaposi's Sarcoma
Posted: November 2nd, 1999, 8:00am MST
Conditions: Sarcoma, Kaposi; HIV Infections
Interventions: Drug: Interferon alfa-2b; Drug: Zidovudine; Drug: Sargramostim
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID)
Completed - verified May 2012 -
Radiation Therapy or Observation Only in Treating Patients With Endometrial Cancer Who Have Undergone Surgery
Posted: November 1st, 1999, 8:00am MST
Condition: Endometrial Cancer
Intervention: Radiation: radiation therapy
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Completed - verified April 2012 -
Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Sarcoma
Posted: November 1st, 1999, 8:00am MST
Condition: Sarcoma
Interventions: Biological: filgrastim; Drug: cisplatin; Drug: doxorubicin hydrochloride; Drug: ifosfamide; Drug: melphalan; Procedure: peripheral blood stem cell transplantation
Sponsors: City of Hope Medical Center; City of Hope Medical Center; National Cancer Institute (NCI)
Active, not recruiting - verified May 2012 -
Radiation Therapy in Treating Patients With Newly Diagnosed Brain Metastases From Kidney Cancer, Melanoma, or Sarcoma
Posted: November 1st, 1999, 8:00am MST
Conditions: Kidney Cancer; Melanoma (Skin); Metastatic Cancer; Ovarian Cancer; Sarcoma
Intervention: Radiation: stereotactic radiosurgery
Sponsors: National Cancer Institute (NCI); Eastern Cooperative Oncology Group; National Cancer Institute (NCI)
Completed - verified July 2003 -
Chemotherapy in Treating Patients With Advanced Sarcoma
Posted: November 1st, 1999, 8:00am MST
Conditions: Ovarian Cancer; Sarcoma
Interventions: Biological: filgrastim; Drug: doxorubicin hydrochloride; Drug: ifosfamide
Sponsors: Swiss Group for Clinical Cancer Research; Swiss Group for Clinical Cancer Research
Completed - verified May 2012 -
Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma
Posted: November 1st, 1999, 8:00am MST
Condition: Sarcoma
Interventions: Biological: dactinomycin; Biological: filgrastim; Biological: sargramostim; Drug: cyclophosphamide; Drug: vincristine sulfate; Radiation: radiation therapy
Sponsors: National Cancer Institute (NCI); Children's Oncology Group; National Cancer Institute (NCI)
Completed - verified November 2010